Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report

Discontinuation of denosumab is associated with the increase of bone turnover markers to above-baseline levels (so-called rebound in bone turnover) and rapid bone loss. Several studies have reported vertebral fractures (VFs), particularly multiple spontaneous clinical VFs (MSCVFs), occurring after d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone Rep
Hlavní autoři: Kashii, Masafumi, Ebina, Kosuke, Kitaguchi, Kazuma, Yoshikawa, Hideki
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284126/
https://ncbi.nlm.nih.gov/pubmed/32548215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100288
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky